Diffuse Redness / Erythema
A hereditary inflammatory condition presenting as persistent redness on the surface of the skin with visible appearance of superficial blood vessels, and mainly affecting the nose, forehead, and cheeks. Common causes include genetics, aging, hormonal changes, ultraviolet exposure, extreme climate changes or lifestyle factors.
Treatment Options:
PURELIGHT G, ELOS PLUS, GENTLEMAX PRO
Treatment Options
Purelight G
PURELIGHT G – controlled wavelengths of green light stimulate photo receptors in dermal layers by directly targeting melanocytes- melanin producing cells located in the epidermal layers. The rise of melanin to the skin surface is prevented by breaking down the melanin deposits in the epidermis. In addition, melanin production and tyrosine activity are minimized, resulting in visible improvement in the appearance of existing discoloration.
Controlled wavelengths of green light stimulate photo receptors in dermal layers by directly targeting melanocytes- melanin producing cells located in the epidermal layers. The rise of melanin to the skin surface is prevented by breaking down the melanin deposits in the epidermis. In addition, melanin production and tyrosine activity are minimized, resulting in visible improvement in the appearance of existing discoloration.
PURELIGHT G can be combined with other procedures, including microdermabrasion and chemical peels, for gentle skin resurfacing and transdermal delivery for optimum penetration of active ingredients.
Treatment Protocol:
Requires a minimum of 6-8 consecutive treatment sessions, 1-3 times per month. Monthly maintenance sessions are recommended.
Elos Plus
Elos Plus technology uses optical energy (intense pulsed light and near infrared light) and bipolar radiofrequency, optimally combined in each pulse and delivered to target tissue to ensure a safe and effective treatment outcome.
Optical energy (laser or light) is converted into thermal energy and selectively absorbed by melanin and hemoglobin in target tissues. Pigmented and vascular lesions are heated to the point of destruction.
An integrated sapphire contact cooling system allows for enhanced patient tolerance.
Elos (electro optical synergy) is established as cutting-edge technology from Syneron-Candela, a leading manufacturer in non-invasive aesthetic procedures.
Elos Plus technology uses optical energy (intense pulsed light and near infrared light) and bipolar radiofrequency, optimally combined in each pulse and delivered to target tissue to ensure a safe and effective treatment outcome.
Pre-heating the area with optical energy allows the radiofrequency to penetrate deeper into the skin’s dermal layers without causing injury to the epidermis.
Fibroblast stimulation and dermal remodeling is initiated through the healing process. Optical energy and bi-polar radiofrequency is also converted to thermal energy for destruction of benign pigmented and vascular lesions.
Elos Plus uses an integrated contact cooling system for enhanced patient tolerance.
Elos Plus treatment indications: benign pigmented and vascular lesions
SR – SRA Plus
SR –SRA Plus is indicated for treatment of pigmented or vascular lesions.
SR Treatment Protocol:
A minimum of 5-6 consecutive treatment sessions, 3-4 weeks apart, are required. Maintenance treatments every 3-6 months are recommended.
SRA Plus – Treatment Protocol:
A minimum of 2-4 consecutive treatment sessions, 3-4 weeks apart, are required post treatment with SR treatment application. Maintenance treatment may be required.
Gentlemax Pro
GentleMax Pro is a dual wavelength laser platform that combines two separate laser sources, a 755 nm Alexandrite laser and a 1064 nm Nd:YAG laser, in a single delivery system.
GentleMax Pro is a dual wavelength laser platform that combines two separate laser sources, a 755 nm Alexandrite laser and a 1064 nm Nd:YAG laser, in a single delivery system.
A controlled amount of therapeutic energy is delivered individually (Alexandrite or Nd:YAG) or optically combined (Alexandrite and Nd:YAG) in each pulse and delivered to target tissues.
Thermal energy is selectively absorbed by target chromophores – melanin or hemoglobin – for destruction of pigmented and vascular lesions in target tissues.
The thermal impact in target tissues stimulates proliferation of fibroblasts cells for enhanced collagen production.
A cryogen cooling system is integrated for enhanced patient tolerance.
Treatment Protocol:
A minimum of 6 consecutive treatment sessions, 3-4 weeks apart, are required.
Monthly maintenance treatments are recommended.